AUSTRALIA: API Reports Strong H1 Growth

Australian Pharmaceutical Industries has reported a strong rise in profits and revenue for its fiscal first half. For the six months to 29 February, net profit grew by 18.1% to A$25.3m, operating profit jumped up 15.6% to A$44.6m, while revenue

The full content of this article is restricted to NamNews Subscribers. If you are an existing user, please log in below. Forgotten your password? Any problems logging in, contact us

Existing Users Log In
 Remember Me